You are here: Home » Markets » News
Green certificates trading may resume from Oct 28 as hearing concludes
Business Standard

PE/VC investments in pharma companies grow 3.5X in 2020, cross $1 bn mark

The reputation and relationships have helped pharma industry raise huge amounts of PE capital in 2020.

Topics
PE/VC investments | Pharma Companies | Pharma industry

T E Narasimhan  |  Chennai 



medicine, drugs, pharma
Over the past three decades India’s manufacturing has had a phenomenal journey establishing it as the world’s third largest manufacturer of drugs by volume

Private Equity (PE)/Venture Capital (VC) investments in pharmaceutical companies have grown by more than 3.5 times in 2020 and for the first time crossed $1 billion to touch $1.69 billion during January to September 2020.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Sun, October 04 2020. 14:35 IST

RECOMMENDED FOR YOU

.